LS

Laxman Singh

Active Director Director DIN 03626108
DIN 03626108 First appointment Nov 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2011
Shareholding value •••• Premium profile

About Laxman Singh

Data last updated:

Laxman Singh is a Director at Lifemax Pharmaceutical Private Limited (since 2011). The company operates in Pharma. Lifemax Pharmaceutical Private Limited reported revenue of ₹24.8 Lakh (FY 2025).

DIN 03626108
Primary Designation Director
Industry Pharma
First Appointment 02 Nov 2011
Oldest Company Age 15 yrs
Largest company Lifemax Pharmaceutical Private Limited · ₹24.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Nov 20112011₹24.8 Lakh (FY 2025)Active

Board colleagues of Laxman Singh

NameDINCompanyDesignation
Swati03626262Lifemax Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lifemax Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Laxman Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Laxman Singh

Laxman Singh currently holds 1 directorship: Lifemax Pharmaceutical Private Limited (Director, since 02 Nov 2011, revenue ₹24.8 Lakh (FY 2025)).

Laxman Singh was first appointed on 02 Nov 2011 as Director at Lifemax Pharmaceutical Private Limited.

The current boards of Laxman Singh's companies include Swati (Lifemax Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available